Literature DB >> 3071456

Comparative trial of ketanserin or bendrofluazide as add-on therapy in hypertensive patients uncontrolled on a beta-blocker alone.

K Korlipara1, S E Gould, N A Taylor, T C Chandler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071456     DOI: 10.2165/00003495-198800361-00026

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  A symptom questionnaire for hypertensive patients.

Authors:  C J Bulpitt; C T Dollery; S Carne
Journal:  J Chronic Dis       Date:  1974-08

2.  The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan.

Authors:  C Idzikowski; P J Cowen; D Nutt; F J Mills
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Ketanserin in essential hypertension: a double-blind, placebo-controlled study.

Authors:  H A Cameron; L E Ramsay
Journal:  Postgrad Med J       Date:  1985-07       Impact factor: 2.401

5.  Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.

Authors:  J M Van Nueten; W J Janssens
Journal:  J Hypertens Suppl       Date:  1986-04

6.  Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.

Authors:  T Hedner; B Persson
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

7.  Ketanserin: haemodynamic effects and mechanism of action.

Authors:  M A Schalekamp; A J Woittiez; G J Wenting; A H van den Meiracker; A J Man in 't Veld
Journal:  J Hypertens Suppl       Date:  1986-04
  7 in total
  3 in total

1.  A placebo-controlled crossover study of ketanserin in elderly hypertensive patients.

Authors:  S T McCarthy; G L McCarthy; S M John; S E Gould
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

2.  Could the increased antihypertensive efficacy of ketanserin in the elderly be due to altered pharmacokinetics?

Authors:  S E Gould; J H Silas; J Hosie
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

3.  Serotonin antagonism reduces the adverse symptoms of beta blockade.

Authors:  K Korlipara; S E Gould; N A Taylor; A Chandler
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.